| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transition metal ion binding | PEPD TRIM49D1 KDM7A THRB ATP7B POLR1A COMMD1 CYP2J2 MYCBP2 F5 | 5.50e-05 | 1189 | 38 | 10 | GO:0046914 |
| GeneOntologyMolecularFunction | copper ion binding | 4.38e-04 | 78 | 38 | 3 | GO:0005507 | |
| GeneOntologyMolecularFunction | rRNA binding | 4.55e-04 | 79 | 38 | 3 | GO:0019843 | |
| GeneOntologyCellularComponent | small-subunit processome | 1.08e-05 | 76 | 38 | 4 | GO:0032040 | |
| GeneOntologyCellularComponent | preribosome | 5.37e-05 | 114 | 38 | 4 | GO:0030684 | |
| GeneOntologyCellularComponent | cytosolic small ribosomal subunit | 7.97e-05 | 46 | 38 | 3 | GO:0022627 | |
| GeneOntologyCellularComponent | small ribosomal subunit | 4.29e-04 | 81 | 38 | 3 | GO:0015935 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.40e-03 | 269 | 38 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | cytosolic ribosome | 1.48e-03 | 124 | 38 | 3 | GO:0022626 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.78e-03 | 287 | 38 | 4 | GO:0035770 | |
| Domain | RIBOSOMAL_S4E | 7.16e-09 | 3 | 37 | 3 | PS00528 | |
| Domain | 40S_S4_C | 7.16e-09 | 3 | 37 | 3 | IPR032277 | |
| Domain | Ribosomal_S4e_N_CS | 7.16e-09 | 3 | 37 | 3 | IPR018199 | |
| Domain | Ribosomal_S4e | 7.16e-09 | 3 | 37 | 3 | PF00900 | |
| Domain | RS4NT | 7.16e-09 | 3 | 37 | 3 | PF08071 | |
| Domain | Ribosomal_S4e_central_region | 7.16e-09 | 3 | 37 | 3 | IPR013845 | |
| Domain | Ribosomal_S4e_N | 7.16e-09 | 3 | 37 | 3 | IPR013843 | |
| Domain | Ribosomal_S4e_central | 7.16e-09 | 3 | 37 | 3 | PD002667 | |
| Domain | 40S_S4_C | 7.16e-09 | 3 | 37 | 3 | PF16121 | |
| Domain | Ribosomal_S4e | 7.16e-09 | 3 | 37 | 3 | IPR000876 | |
| Domain | S4 | 7.14e-08 | 5 | 37 | 3 | PS50889 | |
| Domain | S4 | 7.14e-08 | 5 | 37 | 3 | SM00363 | |
| Domain | S4_RNA-bd | 1.43e-07 | 6 | 37 | 3 | IPR002942 | |
| Domain | KOW | 1.17e-06 | 11 | 37 | 3 | IPR005824 | |
| Domain | KOW | 1.17e-06 | 11 | 37 | 3 | PF00467 | |
| Domain | S4 | 2.29e-05 | 4 | 37 | 2 | PF01479 | |
| Domain | Actinin_actin-bd_CS | 9.41e-04 | 23 | 37 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 9.41e-04 | 23 | 37 | 2 | PS00020 | |
| Domain | ACTININ_1 | 9.41e-04 | 23 | 37 | 2 | PS00019 | |
| Domain | Spectrin | 9.41e-04 | 23 | 37 | 2 | PF00435 | |
| Domain | Spectrin_repeat | 1.50e-03 | 29 | 37 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.82e-03 | 32 | 37 | 2 | IPR018159 | |
| Domain | SPEC | 1.82e-03 | 32 | 37 | 2 | SM00150 | |
| Domain | Quinoprotein_ADH-like_supfam | 4.94e-03 | 53 | 37 | 2 | IPR011047 | |
| Domain | CH | 7.34e-03 | 65 | 37 | 2 | SM00033 | |
| Pathway | REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY | 4.15e-05 | 37 | 26 | 3 | M46427 | |
| Pathway | REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY | 1.09e-04 | 51 | 26 | 3 | M45019 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | 1.78e-04 | 60 | 26 | 3 | M721 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | 2.26e-04 | 65 | 26 | 3 | MM15416 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 2.52e-04 | 13 | 26 | 2 | M4470 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 2.52e-04 | 13 | 26 | 2 | MM1395 | |
| Pathway | REACTOME_MAJOR_PATHWAY_OF_RRNA_PROCESSING_IN_THE_NUCLEOLUS_AND_CYTOSOL | 3.09e-04 | 180 | 26 | 4 | MM15324 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION | 4.32e-04 | 81 | 26 | 3 | M47786 | |
| Pathway | WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS | 4.32e-04 | 81 | 26 | 3 | MM15911 | |
| Pathway | REACTOME_RRNA_PROCESSING | 5.05e-04 | 205 | 26 | 4 | M27685 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION | 6.68e-04 | 94 | 26 | 3 | M29556 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX_EJC | 7.10e-04 | 96 | 26 | 3 | MM15705 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 7.39e-04 | 22 | 26 | 2 | M39480 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 7.39e-04 | 22 | 26 | 2 | M17879 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 7.39e-04 | 22 | 26 | 2 | MM14558 | |
| Pathway | REACTOME_SARS_COV_1_HOST_INTERACTIONS | 7.54e-04 | 98 | 26 | 3 | M46424 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 8.08e-04 | 23 | 26 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 8.08e-04 | 23 | 26 | 2 | MM1427 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 8.08e-04 | 23 | 26 | 2 | MM15936 | |
| Pathway | REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY | 8.47e-04 | 102 | 26 | 3 | M29813 | |
| Pathway | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | 1.14e-03 | 113 | 26 | 3 | M567 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 1.20e-03 | 115 | 26 | 3 | MM15640 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 1.23e-03 | 116 | 26 | 3 | M27921 | |
| Pathway | REACTOME_SELENOAMINO_ACID_METABOLISM | 1.29e-03 | 118 | 26 | 3 | M27170 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_INITIATION | 1.36e-03 | 120 | 26 | 3 | M27686 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_INITIATION | 1.46e-03 | 123 | 26 | 3 | MM15415 | |
| Pathway | REACTOME_SARS_COV_1_INFECTION | 2.24e-03 | 143 | 26 | 3 | M39006 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 2.32e-03 | 39 | 26 | 2 | M2844 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 2.32e-03 | 39 | 26 | 2 | MM14559 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 2.92e-03 | 157 | 26 | 3 | M4669 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_STARVATION | 2.92e-03 | 157 | 26 | 3 | M41835 | |
| Pathway | REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS | 3.78e-03 | 172 | 26 | 3 | M27876 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 4.25e-03 | 53 | 26 | 2 | M39349 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 5.07e-03 | 58 | 26 | 2 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 5.25e-03 | 59 | 26 | 2 | M48343 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 6.08e-03 | 204 | 26 | 3 | M45011 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 6.34e-03 | 65 | 26 | 2 | M38994 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 8808278 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 1783379 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 2124517 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 8187552 | ||
| Pubmed | Structure and function of ribosomal protein S4 genes on the human and mouse sex chromosomes. | 5.21e-09 | 4 | 39 | 3 | 8139551 | |
| Pubmed | Maintenance of X inactivation of the Rps4, Zfx, and Ube1 genes in a mouse in vitro system. | 1.30e-08 | 5 | 39 | 3 | 7681608 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 9562962 | ||
| Pubmed | An evaluation of the inactive mouse X chromosome in somatic cell hybrids. | 4.55e-08 | 7 | 39 | 3 | 8460399 | |
| Pubmed | 4.55e-08 | 7 | 39 | 3 | 7928394 | ||
| Pubmed | Physical mapping of 2000 kb of the mouse X chromosome in the vicinity of the Xist locus. | 7.27e-08 | 8 | 39 | 3 | 8468051 | |
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 9545634 | ||
| Pubmed | SMARCA1 FGB RNF213 MACF1 ZNF536 GPATCH4 ATP7B EML5 ATAD5 BRD9 | 3.03e-07 | 1116 | 39 | 10 | 31753913 | |
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 3.70e-07 | 13 | 39 | 3 | 1740345 | |
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 3.70e-07 | 13 | 39 | 3 | 1772416 | |
| Pubmed | Developmental expression of Commd1 in the liver of the Jackson toxic milk mouse. | 1.23e-06 | 2 | 39 | 2 | 17910951 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20433422 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8358435 | ||
| Pubmed | 1.47e-06 | 20 | 39 | 3 | 16635246 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17582472 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18974300 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17919502 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12747593 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 22677543 | ||
| Pubmed | Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. | 3.67e-06 | 3 | 39 | 2 | 22708584 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20082208 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 20064497 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 22130675 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 18253477 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15091001 | ||
| Pubmed | The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients. | 7.34e-06 | 4 | 39 | 2 | 20051843 | |
| Pubmed | 8.32e-06 | 35 | 39 | 3 | 15031101 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 14963283 | ||
| Pubmed | Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women. | 1.22e-05 | 5 | 39 | 2 | 28603947 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12122980 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 16353042 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 18284606 | ||
| Pubmed | The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein. | 1.22e-05 | 5 | 39 | 2 | 12968035 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 17230042 | ||
| Pubmed | Connection between genetically determined blood coagulation factors and haemorheology. | 1.83e-05 | 6 | 39 | 2 | 18503143 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 12518110 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 10829076 | ||
| Pubmed | Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? | 1.83e-05 | 6 | 39 | 2 | 16938111 | |
| Pubmed | [Pharmacogenetics of the local thrombolysis in patients with deep vein thrombosis]. | 1.83e-05 | 6 | 39 | 2 | 16466010 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 17994314 | ||
| Pubmed | Characterization of COMMD protein-protein interactions in NF-kappaB signalling. | 1.83e-05 | 6 | 39 | 2 | 16573520 | |
| Pubmed | Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. | 1.83e-05 | 6 | 39 | 2 | 16157382 | |
| Pubmed | 2.43e-05 | 1442 | 39 | 9 | 35575683 | ||
| Pubmed | 2.56e-05 | 152 | 39 | 4 | 34299191 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 18057060 | ||
| Pubmed | Early pregnancy loss in celiac women: The role of genetic markers of thrombophilia. | 2.56e-05 | 7 | 39 | 2 | 19395327 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 16567932 | ||
| Pubmed | Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population. | 2.56e-05 | 7 | 39 | 2 | 15968394 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 16635210 | ||
| Pubmed | A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. | 2.56e-05 | 7 | 39 | 2 | 16324093 | |
| Pubmed | Thrombophilic gene polymorphisms are risk factors for unexplained infertility. | 2.56e-05 | 7 | 39 | 2 | 18930220 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 19682239 | ||
| Pubmed | 3.11e-05 | 54 | 39 | 3 | 18495661 | ||
| Pubmed | Impact of genetic polymorphisms on platelet function and aspirin resistance. | 4.39e-05 | 9 | 39 | 2 | 19923980 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 16420563 | ||
| Pubmed | Candidate genetic markers and the risk of restenosis after coronary angioplasty. | 4.39e-05 | 9 | 39 | 2 | 12899665 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 12615788 | ||
| Pubmed | 5.22e-05 | 601 | 39 | 6 | 33658012 | ||
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 14706682 | ||
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 19072566 | ||
| Pubmed | Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction. | 5.48e-05 | 10 | 39 | 2 | 20036902 | |
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 19906129 | ||
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 17111197 | ||
| Pubmed | Vascular at-risk genotypes and disease severity in Lebanese sickle cell disease patients. | 5.48e-05 | 10 | 39 | 2 | 20425806 | |
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 19560472 | ||
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 10454579 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 7.03e-05 | 197 | 39 | 4 | 20811636 | |
| Pubmed | 8.00e-05 | 74 | 39 | 3 | 29795351 | ||
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 12514663 | ||
| Pubmed | Gene variants associated with venous thrombosis: confirmation in the MEGA study. | 8.03e-05 | 12 | 39 | 2 | 20128871 | |
| Pubmed | 8.66e-05 | 76 | 39 | 3 | 27542412 | ||
| Pubmed | 8.89e-05 | 407 | 39 | 5 | 12693553 | ||
| Pubmed | Genetic cardiovascular risk factors and age-related macular degeneration. | 9.48e-05 | 13 | 39 | 2 | 19860767 | |
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 14660691 | ||
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 18848323 | ||
| Pubmed | Genetic influences on blood pressure within the Stanislas Cohort. | 9.48e-05 | 13 | 39 | 2 | 15076187 | |
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 17003923 | ||
| Pubmed | 1.09e-04 | 82 | 39 | 3 | 25901680 | ||
| Pubmed | Gene polymorphisms in association with emerging cardiovascular risk markers in adult women. | 1.11e-04 | 14 | 39 | 2 | 20078877 | |
| Pubmed | 1.13e-04 | 83 | 39 | 3 | 19799774 | ||
| Pubmed | 1.21e-04 | 85 | 39 | 3 | 36517592 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.27e-04 | 1024 | 39 | 7 | 24711643 | |
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 10567404 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.45e-04 | 724 | 39 | 6 | 36232890 | |
| Pubmed | Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. | 1.73e-04 | 96 | 39 | 3 | 21529712 | |
| Pubmed | 1.76e-04 | 250 | 39 | 4 | 33536335 | ||
| Pubmed | 1.84e-04 | 98 | 39 | 3 | 9507200 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.87e-04 | 759 | 39 | 6 | 35915203 | |
| Pubmed | 2.01e-04 | 101 | 39 | 3 | 9872452 | ||
| Pubmed | 2.06e-04 | 1487 | 39 | 8 | 33957083 | ||
| Pubmed | 2.16e-04 | 1497 | 39 | 8 | 31527615 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.17e-04 | 264 | 39 | 4 | 32814769 | |
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 2.20e-04 | 104 | 39 | 3 | 26167872 | |
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 21689717 | ||
| Pubmed | Candidate genes and cerebral palsy: a population-based study. | 2.54e-04 | 21 | 39 | 2 | 18977990 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 2.59e-04 | 110 | 39 | 3 | 37219487 | |
| GeneFamily | S ribosomal proteins | 1.93e-05 | 34 | 28 | 3 | 728 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_STELLATE_CELL_AGEING | 2.35e-07 | 9 | 38 | 3 | MM3821 | |
| Coexpression | BILANGES_SERUM_RESPONSE_TRANSLATION | 1.94e-05 | 36 | 38 | 3 | MM1308 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FIBROBLAST_AGEING | 2.48e-05 | 39 | 38 | 3 | MM3721 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | 2.84e-05 | 418 | 38 | 6 | MM3752 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NON_CLASSICAL_MONOCYTE_AGEING | 4.95e-05 | 49 | 38 | 3 | MM3772 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN | 6.71e-05 | 151 | 38 | 4 | M369 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 1.24e-04 | 177 | 38 | 4 | M7632 | |
| Coexpression | BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES | 1.63e-04 | 73 | 38 | 3 | MM1304 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 1.77e-04 | 75 | 38 | 3 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.77e-04 | 75 | 38 | 3 | MM3718 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN | 1.83e-04 | 196 | 38 | 4 | M8034 | |
| Coexpression | KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP | 1.98e-04 | 200 | 38 | 4 | M3012 | |
| Coexpression | KIM_MYC_AMPLIFICATION_TARGETS_UP | 2.06e-04 | 202 | 38 | 4 | M8445 | |
| Coexpression | TABULA_MURIS_SENIS_THYMUS_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 2.22e-04 | 81 | 38 | 3 | MM3848 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 2.50e-04 | 394 | 38 | 5 | MM3724 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 2.65e-04 | 86 | 38 | 3 | M39248 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_500 | 5.55e-05 | 120 | 37 | 4 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k3_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | 5.69e-05 | 395 | 37 | 6 | GSM538351_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_100 | 1.32e-04 | 10 | 37 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_100 | 1.32e-04 | 10 | 37 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_100 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.20e-07 | 199 | 39 | 5 | 892ca0dc9928d3985bf99de8afc68c06d22e6e2e | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.88e-06 | 135 | 39 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 181 | 39 | 4 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 181 | 39 | 4 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.03e-05 | 185 | 39 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 185 | 39 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 185 | 39 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 39 | 4 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 39 | 4 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 2.26e-05 | 190 | 39 | 4 | 5624f711b34132081f93fa70702316962e3e3c64 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.30e-05 | 191 | 39 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 2.40e-05 | 193 | 39 | 4 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-05 | 196 | 39 | 4 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.55e-05 | 196 | 39 | 4 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-05 | 199 | 39 | 4 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.76e-05 | 200 | 39 | 4 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.62e-04 | 121 | 39 | 3 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 147 | 39 | 3 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 147 | 39 | 3 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.41e-04 | 156 | 39 | 3 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 156 | 39 | 3 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 156 | 39 | 3 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 157 | 39 | 3 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 157 | 39 | 3 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-04 | 158 | 39 | 3 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-04 | 158 | 39 | 3 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.95e-04 | 164 | 39 | 3 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.46e-04 | 171 | 39 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.85e-04 | 176 | 39 | 3 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.93e-04 | 177 | 39 | 3 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.93e-04 | 177 | 39 | 3 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.93e-04 | 177 | 39 | 3 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.93e-04 | 177 | 39 | 3 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.93e-04 | 177 | 39 | 3 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 178 | 39 | 3 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.01e-04 | 178 | 39 | 3 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-04 | 179 | 39 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.09e-04 | 179 | 39 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 179 | 39 | 3 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 179 | 39 | 3 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 179 | 39 | 3 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 5.18e-04 | 180 | 39 | 3 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 5.18e-04 | 180 | 39 | 3 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 5.43e-04 | 183 | 39 | 3 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 5.43e-04 | 183 | 39 | 3 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.43e-04 | 183 | 39 | 3 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3|World / Primary Cells by Cluster | 5.52e-04 | 184 | 39 | 3 | 907ba412166bcb0526c5be0b06a76b6bd37c5a35 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-04 | 184 | 39 | 3 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 5.52e-04 | 184 | 39 | 3 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 5.52e-04 | 184 | 39 | 3 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.61e-04 | 185 | 39 | 3 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.61e-04 | 185 | 39 | 3 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.61e-04 | 185 | 39 | 3 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.69e-04 | 186 | 39 | 3 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-04 | 187 | 39 | 3 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-04 | 187 | 39 | 3 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.78e-04 | 187 | 39 | 3 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-04 | 187 | 39 | 3 | cfdc1585c80d2bb475d9145395fb50a88c53f838 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.78e-04 | 187 | 39 | 3 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-04 | 187 | 39 | 3 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 5.87e-04 | 188 | 39 | 3 | 21730497f95dc271e4cdfaaf1da8b9ac6eec2ded | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.97e-04 | 189 | 39 | 3 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-04 | 189 | 39 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 6.06e-04 | 190 | 39 | 3 | 5dca8654964c41580fa3b094579fe7cb296d406f | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-04 | 190 | 39 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 6.06e-04 | 190 | 39 | 3 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.06e-04 | 190 | 39 | 3 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.24e-04 | 192 | 39 | 3 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.24e-04 | 192 | 39 | 3 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.24e-04 | 192 | 39 | 3 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.24e-04 | 192 | 39 | 3 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.24e-04 | 192 | 39 | 3 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.24e-04 | 192 | 39 | 3 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.24e-04 | 192 | 39 | 3 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1|World / Primary Cells by Cluster | 6.24e-04 | 192 | 39 | 3 | bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.34e-04 | 193 | 39 | 3 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 193 | 39 | 3 | 6995ee29bf403a71247de92a37dfd851be5acf2e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.34e-04 | 193 | 39 | 3 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 6.34e-04 | 193 | 39 | 3 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.34e-04 | 193 | 39 | 3 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 6.34e-04 | 193 | 39 | 3 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.34e-04 | 193 | 39 | 3 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.43e-04 | 194 | 39 | 3 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | severe_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 6.43e-04 | 194 | 39 | 3 | bdafc1173b7b8cde8714573fbeee5394a2484a5f | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_TEM|IIF / Disease, Lineage and Cell Type | 6.43e-04 | 194 | 39 | 3 | f4f7c85963ba52ee7ca2ef5657e60680fe6332fe | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-04 | 194 | 39 | 3 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-04 | 194 | 39 | 3 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | CV-Moderate-0|CV / Virus stimulation, Condition and Cluster | 6.43e-04 | 194 | 39 | 3 | 9ff69139dae007fcc349daefcb5021defb0e0d2a | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 6.53e-04 | 195 | 39 | 3 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.53e-04 | 195 | 39 | 3 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 6.53e-04 | 195 | 39 | 3 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.79e-04 | 50 | 24 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Disease | thrombosis (is_implicated_in) | 1.59e-04 | 15 | 37 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | myocardial infarction (is_implicated_in) | 2.62e-04 | 99 | 37 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | Liver Cirrhosis | 2.94e-04 | 103 | 37 | 3 | C0023890 | |
| Disease | Fibrosis, Liver | 3.12e-04 | 105 | 37 | 3 | C0239946 | |
| Disease | mean corpuscular hemoglobin concentration | 3.90e-04 | 1105 | 37 | 7 | EFO_0004528 | |
| Disease | D dimer measurement | 6.51e-04 | 30 | 37 | 2 | EFO_0004507 | |
| Disease | pulmonary hypertension (is_implicated_in) | 6.51e-04 | 30 | 37 | 2 | DOID:6432 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.09e-03 | 364 | 37 | 4 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | end stage renal disease (is_implicated_in) | 1.22e-03 | 41 | 37 | 2 | DOID:783 (is_implicated_in) | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 1.73e-03 | 49 | 37 | 2 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKITMKEEWHKFIQL | 1481 | Q96QE3 | |
| WKKLKLFVSHMIDKH | 251 | P51589 | |
| MGKKHKKHKAEWRSS | 1 | Q9H8M2 | |
| LDHKMEIKQWKKSFL | 641 | P35670 | |
| TWMGKIHSKEHFKEK | 106 | P12955 | |
| VLLHHWKALKKVNMK | 241 | Q3KRB8 | |
| LKHQHLKKKALREKW | 36 | Q9NP74 | |
| GVKALHTALKLWMKK | 431 | Q6ZMT4 | |
| KKKKRWHHEEEKMGV | 291 | Q5T3I0 | |
| SWSFHKLKTMKHLLL | 6 | P02675 | |
| KWVNKHLMKVRKHIN | 86 | Q9UPN3 | |
| HKKATKWMNWKHLKE | 351 | Q86Z20 | |
| KFWKSHKTKIRESLM | 96 | Q8N668 | |
| FKEAWKHAIQKAKHM | 81 | O00418 | |
| KLITAGIKHMKFWRK | 831 | Q05BV3 | |
| IWKKHYIQMVKELHI | 151 | Q8IX29 | |
| KMFWEKKIEHHARHL | 26 | A0A1B0GVR7 | |
| ESKSKLIALFWKAHM | 186 | O95602 | |
| EMVIKEKSVFKKFHW | 291 | P28370 | |
| LKWAFSKHETAKNKM | 2121 | Q8NF91 | |
| AKHRFSWMKLLAHKV | 876 | P12259 | |
| KKHLKRVAAPKHWML | 6 | P22090 | |
| KKHLKRVAAPKHWML | 6 | Q8TD47 | |
| KKKLKFCKSHIHDWG | 1826 | Q9UPS6 | |
| KKAALMHKWPLKEIS | 346 | O75592 | |
| KSMVHKKAWLISAKQ | 236 | P08F94 | |
| KKHLKRVAAPKHWML | 6 | P62701 | |
| LSPHKIKHTKKSWAM | 286 | Q2KHM9 | |
| KGAKEKMKEESWHIH | 471 | Q66K14 | |
| KIHRSKNKWKFHLKD | 341 | P52655 | |
| SAFMKHLKKLWKALD | 1486 | Q63HN8 | |
| LKLHNKKLAAFWLMK | 271 | Q96DB5 | |
| LWTHKLLMLHGQKLK | 821 | Q15269 | |
| KHHVTHFWPKLLMKV | 411 | P10828 | |
| WFLKNHMKVHLNKLS | 386 | O15090 | |
| HREKLLKKMQSLWEK | 136 | C9J1S8 | |
| TLEPLHTLLHMKWKK | 421 | Q8NET8 | |
| HTLLHMKWKKFAKHM | 426 | Q8NET8 | |
| KSFKKLWSLHEHIKI | 306 | Q9Y2D9 | |
| KKVMKRLKSEVWHHF | 451 | O75132 |